Resultados de la búsqueda 161-170 of 14357 for Acute gout

  1. Hematología - Ensayos clínicos - Mayo Clinic

    This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic Leukemia ...

  2. Hematología - Ensayos clínicos - Mayo Clinic

    ... Acute Lymphoblastic Leukemia (B-ALL) improves outcomes. This trial also studies the outcomes of patients with mixed phenotype acute leukemia (MPAL), and B ...

  3. Cirugía - Ensayos clínicos - Mayo Clinic

    Acute Modulation of Stereotyped High-Frequency Oscillations. Rochester, Minn. The purpose of this study is to do data collection of EEG findings to determine ...

  4. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic Leukemia ...

  5. Cirugía - Ensayos clínicos - Mayo Clinic

    Acute Modulation of Stereotyped High-Frequency Oscillations. Rochester, Minn. The purpose of this study is to do data collection of EEG findings to determine ...

  6. Neurología - Ensayos clínicos - Mayo Clinic

    A total of 8,000 patients presenting to CPSs with acute-onset AIS, ICH or aSAH and no history of dementia will be enrolled within 6 weeks of stroke onset.

  7. Gangrena

    Hyperbaric oxygen therapy. https://www.uptodate.com/contents/search. Accessed April 8, 2022. Novara E, et al. Severe acute dried gangrene in ...

  8. Deficiencia de alfa-1 antitripsina

    Learn about alpha-1 antitrypsin deficiency. American Lung Association. https://www.lung.org/lung-health-diseases/lung-disease-lookup/alpha-1-antitrypsin- ...

  9. Neurología - Ensayos clínicos - Mayo Clinic

    A total of 8,000 patients presenting to CPSs with acute-onset AIS, ICH or aSAH and no history of dementia will be enrolled within 6 weeks of stroke onset.

  10. Cirugía - Ensayos clínicos - Mayo Clinic

    The hypothesis is that the early surgery group will have a significantly lower all-cause mortality and incidence of acute aortic events at 2 years of follow up ...